David Caudell to Oncogene Proteins, Fusion
This is a "connection" page, showing publications David Caudell has written about Oncogene Proteins, Fusion.
Connection Strength
1.172
-
Puthiyaveetil AG, Heid B, Reilly CM, HogenEsch H, Caudell DL. A NUP98-HOXD13 leukemic fusion gene leads to impaired class switch recombination and antibody production. Exp Hematol. 2012 Aug; 40(8):622-33.
Score: 0.416
-
Caudell D, Harper DP, Novak RL, Pierce RM, Slape C, Wolff L, Aplan PD. Retroviral insertional mutagenesis identifies Zeb2 activation as a novel leukemogenic collaborating event in CALM-AF10 transgenic mice. Blood. 2010 Feb 11; 115(6):1194-203.
Score: 0.351
-
Caudell D, Zhang Z, Chung YJ, Aplan PD. Expression of a CALM-AF10 fusion gene leads to Hoxa cluster overexpression and acute leukemia in transgenic mice. Cancer Res. 2007 Sep 01; 67(17):8022-31.
Score: 0.300
-
Novak RL, Harper DP, Caudell D, Slape C, Beachy SH, Aplan PD. Gene expression profiling and candidate gene resequencing identifies pathways and mutations important for malignant transformation caused by leukemogenic fusion genes. Exp Hematol. 2012 Dec; 40(12):1016-27.
Score: 0.106